Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Chen, X. Wang, W. Yao, C. Tang (Beijing, China). Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease. Eur Respir J 2011; 38: Suppl. 55, 4043

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 617s Year: 2007 Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008 Exhaled hydrogen peroxide in patients with stable chronic obstructive pulmonary disease: effect of cigarette smoking Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 Exhaled breath condensate pH and exhaled nitric oxide in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 18s Year: 2003 Exhaled NO and pulmonary function in children with inflammatory bowel diseases Source: Annual Congress 2007 - Clinical outcome studies and technical aspects of paediatric lung function testing Year: 2007 The concentration of inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 pH in exhaled breath condensate of patients with inflammatory airway diseases Source: Eur Respir J 2003; 22: Suppl. 45, 240s Year: 2003 Superiority of hydrogen peroxide to exhaled nitric oxide as a marker of bronchial inflammation in asthmatic children Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008 The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001 Exhaled markers in the monitoring of airways inflammation in mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 679s Year: 2004 Correlation of H2O2, pH and nitrite/nitrate in exhaled breath condensate and systemic inflammatory parameters during and after acute COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 349s Year: 2005 Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Increased concentration of hydrogen peroxide (H2O2) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010 Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005 Exhaled breath condensate: hydrogen peroxide Source: Eur Respir Monogr 2010; 49: 162-172 Year: 2010